1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Recurrent B Acute Lymphoblastic Leukemia: new trials by email Literature Review of Recurrent B Acute Lymphoblastic Leukemia trials Research Report on Recurrent B Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Asparaginase, Blinatumomab - Recurrent B Acute Lymphoblastic Leukemia | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 669 | 2014-12-17 | 2026-11-18 |
Burkitt Lymphoma (1)
DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Tumor Virus Infections (1)
Asparaginase (1) · Calcium Dobesilate (1) · Cyclophosphamide (1) · Cytarabine (1) · Dexamethasone (1) · Etoposide (1) · Hydrocortisone (1) · Leucovorin (1) · Leyk (1) · Mercaptopurine (1) · Methotrexate (1) · Mitoxantrone (1) · N,N-dicyclohexyl-isoborneol-10-sulfonamide (1) · Radiation (1) · Radiotherapy (1)
National Cancer Institute (NCI) (1)
Australia (1) · Canada (1) · New Zealand (1) · Puerto Rico (1) · United States (1)
Patrick A Brown (1)
PMID 33651090, PMID 37257143, PMID 40568722
U10CA098543 (1), U10CA180886 (1)